Spatiotemporal Characterization of mTOR Kinase Activity Following Kainic Acid Induced Status Epilepticus and Analysis of Rat Brain Response to Chronic Rapamycin Treatment

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Macias, Matylda ^a   Blazejczyk, Magdalena ^a   Kazmierska, Paulina ^b   Caban, Bartosz ^b   Skalecka, Agnieszka ^a   Tarkowski, Bartosz ^a   Rodo, Anna ^c   Konopacki, Jan ^b   Jaworski, Jacek ^a  

^a INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN;

ANATOMICAL VARIATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR CHANGE; BRAIN CORTEX; BRAIN REGION; BRAIN SLICE; CELLULAR DISTRIBUTION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; EPILEPTIC STATE; HIPPOCAMPUS; MALE; MOLECULAR DYNAMICS; NONHUMAN; RAT; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ASTROCYTES; BRAIN; CELL DEATH; CELL NUCLEUS; HIPPOCAMPUS; KAINIC ACID; MALE; NEURONS; PHOSPHORYLATION; PHOSPHOSERINE; RATS; RATS, WISTAR; RIBOSOMAL PROTEIN S6; SEIZURES; SIGNAL TRANSDUCTION; SIROLIMUS; SPATIO-TEMPORAL ANALYSIS; STATUS EPILEPTICUS; SUBCELLULAR FRACTIONS; TOR SERINE-THREONINE KINASES;

ANIMALIA; MAMMALIA; RATTUS;

EID: 84878396610     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064455     Document Type: Article

References (73)

1. Sengupta S, Peterson TR, Sabatini DM, (2010) Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Molecular Cell 40: 310-322.
2. Lenz G, Avruch J, (2005) Glutamatergic regulation of the p70S6 kinase in primary mouse neurons. The Journal of Biological Chemistry 280: 38121-38124.
3. Garelick MG, Kennedy BK, (2011) TOR on the brain. Experimental Gerontology 46: 155-163.
4. Swiech L, Perycz M, Malik A, Jaworski J, (2008) Role of mTOR in physiology and pathology of the nervous system. Biochimica Et Biophysica Acta 1784: 116-132.
5. Hoeffer CA, Klann E, (2010) mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci 33: 67-75.
6. Faghiri Z, Bazan NG, (2010) PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Experimental Eye Research 90: 718-725.
7. Paglin S, Lee N-Y, Nakar C, Fitzgerald M, Plotkin J, et al. (2005) Rapamycin-sensitive pathway regulates mitochondrial membrane potential, autophagy, and survival in irradiated MCF-7 cells. Cancer Research 65: 11061-11070.
8. Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M, (2005) Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 25: 11300-11312.
9. Kumar V, Zhang M-X, Swank MW, Kunz J, Wu G-Y, (2005) Regulation of dendritic morphogenesis by Ras-PI3K-Akt-mTOR and Ras-MAPK signaling pathways. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 25: 11288-11299.
10. Morita T, Sobue K, (2009) Specification of neuronal polarity regulated by local translation of CRMP2 and Tau via the mTOR-p70S6K pathway. The Journal of Biological Chemistry 284: 27734-27745.
11. Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, et al. (2006) Hypothalamic mTOR signaling regulates food intake. Science 312: 927-930.
12. Cao R, Li A, Cho HY, Lee B, Obrietan K, (2010) Mammalian target of rapamycin signaling modulates photic entrainment of the suprachiasmatic circadian clock. J Neurosci 30: 6302-6314.
13. The enzymes. New York: Academic Press.
14. Kwiatkowski DJ, (2003) Tuberous sclerosis: from tubers to mTOR. Annals of Human Genetics 67: 87-96.
15. Kwiatkowski DJ, (2003) Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis. Cancer Biology & Therapy 2: 471-476.
16. Shacka JJ, Lu J, Xie Z-L, Uchiyama Y, Roth KA, et al. (2007) Kainic acid induces early and transient autophagic stress in mouse hippocampus. Neuroscience Letters 414: 57-60.
17. Zeng L-H, Rensing NR, Wong M, (2009) The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 29: 6964-6972.
18. Buckmaster PS, Ingram EA, Wen X, (2009) Inhibition of the mammalian target of rapamycin signaling pathway suppresses dentate granule cell axon sprouting in a rodent model of temporal lobe epilepsy. The Journal of Neuroscience: The Official AZSJournal of the Society for Neuroscience 29: 8259-8269.
19. Wong M, (2010) Mammalian target of rapamycin (mTOR) inhibition as a potential antiepileptogenic therapy: From tuberous sclerosis to common acquired epilepsies. Epilepsia 51: 27-36.
20. McDaniel SS, Wong M, (2011) Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neuroscience Letters 497: 231-239.
21. Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, et al. (2008) Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 28: 5422-5432.
22. Zeng L-H, Xu L, Gutmann DH, Wong M, (2008) Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Annals of Neurology 63: 444-453.
23. Huang X, Zhang H, Yang J, Wu J, McMahon J, et al. (2010) Pharmacological inhibition of the mammalian target of rapamycin pathway suppresses acquired epilepsy. Neurobiology of Disease 40: 193-199.
24. Buckmaster PS, Lew FH, (2011) Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 31: 2337-2347.
25. Buckmaster PS, Wen X, (2011) Rapamycin suppresses axon sprouting by somatostatin interneurons in a mouse model of temporal lobe epilepsy. Epilepsia 52: 2057-2064.
26. Sunnen CN, Brewster AL, Lugo JN, Vanegas F, Turcios E, et al. (2011) Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice. Epilepsia 52: 2065-2075.
27. Gangloff YG, Mueller M, Dann SG, Svoboda P, Sticker M, et al. (2004) Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol Cell Biol 24: 9508-9516.
28. Murakami M, Ichisaka T, Maeda M, Oshiro N, Hara K, et al. (2004) mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells. Mol Cell Biol 24: 6710-6718.
29. Stoica L, Zhu PJ, Huang W, Zhou H, Kozma SC, et al. (2011) Selective pharmacogenetic inhibition of mammalian target of Rapamycin complex I (mTORC1) blocks long-term synaptic plasticity and memory storage. Proc Natl Acad Sci U S A 108: 3791-3796.
30. Caccamo A, Majumder S, Richardson A, Strong R, Oddo S, (2010) Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J Biol Chem 285: 13107-13120.
31. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, et al. (2012) Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell 11: 326-335.
32. Tischmeyer W, Schicknick H, Kraus M, Seidenbecher CI, Staak S, et al. (2003) Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory. Eur J Neurosci 18: 942-950.
33. Parsons RG, Gafford GM, Helmstetter FJ, (2006) Translational control via the mammalian target of rapamycin pathway is critical for the formation and stability of long-term fear memory in amygdala neurons. J Neurosci 26: 12977-12983.
34. Deli A, Schipany K, Rosner M, Hoger H, Pollak A, et al. (2012) Blocking mTORC1 activity by rapamycin leads to impairment of spatial memory retrieval but not acquisition in C57BL/6J mice. Behav Brain Res 229: 320-324.
35. Zeng LH, McDaniel S, Rensing NR, Wong M, (2010) Regulation of cell death and epileptogenesis by the mammalian target of rapamycin (mTOR): a double-edged sword? Cell Cycle 9: 2281-2285.
36. Hellier JL, Patrylo PR, Buckmaster PS, Dudek FE, (1998) Recurrent spontaneous motor seizures after repeated low-dose systemic treatment with kainate: assessment of a rat model of temporal lobe epilepsy. Epilepsy Res 31: 73-84.
37. Swiech L, Blazejczyk M, Urbanska M, Pietruszka P, Dortland BR, et al. (2011) CLIP-170 and IQGAP1 cooperatively regulate dendrite morphology. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 31: 4555-4568.
38. Paxinos G, Watson C (2004) The Rat Brain in Stereotaxic Coordinates- The New Coronal Set, Fifth Edition: Academic Press.
39. Zinzalla V, Sturgill TW, Hall MN (2010) TOR Complexes: Composition, Structure, and Phosphorylation. In: Hall MN, Tamanoi F, editors. Structure, function and regulation of TOR complexes from yeasts to mammals Part A. Amsterdam, Boston: Elsevier. 1-15.
40. Bachmann RA, Kim J-H, Wu A-L, Park I-H, Chen J, (2006) A nuclear transport signal in mammalian target of rapamycin is critical for its cytoplasmic signaling to S6 kinase 1. The Journal of Biological Chemistry 281: 7357-7363.
41. Park I-H, Bachmann R, Shirazi H, Chen J, (2002) Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin. The Journal of Biological Chemistry 277: 31423-31429.
42. Takei N, Inamura N, Kawamura M, Namba H, Hara K, et al. (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 24: 9760-9769.
43. Ljungberg MC, Bhattacharjee MB, Lu Y, Armstrong DL, Yoshor D, et al. (2006) Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia. Annals of Neurology 60: 420-429.
44. Willoughby JO, Mackenzie L, Medvedev A, Hiscock JJ, (1997) Fos induction following systemic kainic acid: early expression in hippocampus and later widespread expression correlated with seizure. Neuroscience 77: 379-392.
45. Herdegen T, Leah JD, (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 28: 370-490.
46. Popovici T, Represa A, Crepel V, Barbin G, Beaudoin M, et al. (1990) Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res 536: 183-194.
47. Moore CE, Xie J, Gomez E, Herbert TP, (2009) Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic beta-cells. J Mol Biol 389: 480-494.
48. Roux PP, Shahbazian D, Vu H, Holz MK, Cohen MS, et al. (2007) RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation. J Biol Chem 282: 14056-14064.
49. Ruvinsky I, Meyuhas O, (2006) Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci 31: 342-348.
50. Jabs R, Seifert G, Steinhäuser C, (2008) Astrocytic function and its alteration in the epileptic brain. Epilepsia 49Suppl 2: 3-12.
51. Wetherington J, Serrano G, Dingledine R, (2008) Astrocytes in the epileptic brain. Neuron 58: 168-178.
52. Friedman A, Kaufer D, Heinemann U, (2009) Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Research 85: 142-149.
53. Gajda Z, Szupera Z, Blazso G, Szente M, (2005) Quinine, a blocker of neuronal cx36 channels, suppresses seizure activity in rat neocortex in vivo. Epilepsia 46: 1581-1591.
54. Bostanci MO, Bagirici F, (2007) Anticonvulsive effects of carbenoxolone on penicillin-induced epileptiform activity: an in vivo study. Neuropharmacology 52: 362-367.
55. Tsang CK, Liu H, Zheng XFS, (2010) mTOR binds to the promoters of RNA polymerase I- and III-transcribed genes. Cell Cycle (Georgetown, Tex) 9: 953-957.
56. Shor B, Wu J, Shakey Q, Toral-Barza L, Shi C, et al. (2010) Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J Biol Chem 285: 15380-15392.
57. Malik AR, Urbanska M, Macias M, Skalecka A, Jaworski J (2012) Beyond control of protein translation: What we have learned about the non-canonical regulation and function of mammalian target of rapamycin (mTOR). Biochim Biophys Acta.
58. Sha LZ, Xing XL, Zhang D, Yao Y, Dou WC, et al. (2012) Mapping the spatio-temporal pattern of the mammalian target of rapamycin (mTOR) activation in temporal lobe epilepsy. PLoS One 7: e39152.
59. Takei N, Inamura N, Kawamura M, Namba H, Hara K, et al. (2004) Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J Neurosci 24: 9760-9769.
60. Wetmore C, Olson L, Bean AJ, (1994) Regulation of brain-derived neurotrophic factor (BDNF) expression and release from hippocampal neurons is mediated by non-NMDA type glutamate receptors. J Neurosci 14: 1688-1700.
61. Sperk G, Lassmann H, Baran H, Kish SJ, Seitelberger F, et al. (1983) Kainic acid induced seizures: neurochemical and histopathological changes. Neuroscience 10: 1301-1315.
62. Binder DK, Steinhäuser C, (2006) Functional changes in astroglial cells in epilepsy. Glia 54: 358-368.
63. Codeluppi S, Svensson CI, Hefferan MP, Valencia F, Silldorff MD, et al. (2009) The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 29: 1093-1104.
64. Lisi L, Navarra P, Feinstein DL, Dello Russo C, (2011) The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes. J Neuroinflammation 8: 1.
65. Binder DK, Yao X, Zador Z, Sick TJ, Verkman AS, et al. (2006) Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels. Glia 53: 631-636.
66. Djukic B, Casper KB, Philpot BD, Chin L-S, McCarthy KD, (2007) Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 27: 11354-11365.
67. Busch SA, Silver J, (2007) The role of extracellular matrix in CNS regeneration. Current Opinion in Neurobiology 17: 120-127.
68. Silver J, Miller JH, (2004) Regeneration beyond the glial scar. Nature Reviews Neuroscience 5: 146-156.
69. Sliwa A, Plucinska G, Bednarczyk J, Lukasiuk K (2011) Post-treatment with rapamycin does not prevent epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Neurosci Lett.
70. Oby E, Janigro D, (2006) The blood-brain barrier and epilepsy. Epilepsia 47: 1761-1774.
71. Ruegg S, Baybis M, Juul H, Dichter M, Crino PB, (2007) Effects of rapamycin on gene expression, morphology, and electrophysiological properties of rat hippocampal neurons. Epilepsy Res 77: 85-92.
72. Kwon C-H, Zhu X, Zhang J, Baker SJ, (2003) mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proceedings of the National Academy of Sciences of the United States of America 100: 12923-12928.
73. Fang Y, Westbrook R, Hill C, Boparai RK, Arum O, et al. (2013) Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab 17: 456-462.